Cargando…

Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer

OBJECTIVE: The objectives of this review are to discuss: the definition, clinical and biologic features of oligometastatic non-small cell lung cancer (NSCLC), as well as the concept of treating oligoprogression in oligometastatic NSCLC. BACKGROUND: A substantial proportion of patients diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rashdan, Sawsan, Iyengar, Puneeth, Minna, John D., Gerber, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Oligometastatic NSCLC: Definition and Treatment Opportunities
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350108/ https://www.ncbi.nlm.nih.gov/pubmed/34430372 http://dx.doi.org/10.21037/tlcr-21-448

Ejemplares similares

Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review
por: Tjong, Michael C., et al.
Publicado: (2021)

Oligometastatic non-small cell lung cancer: from biology to clinical practice
por: Infante, Maurizio V., et al.
Publicado: (2021)

Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
por: Sundahl, Nora, et al.
Publicado: (2021)

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021)

A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
por: Belluomini, Lorenzo, et al.
Publicado: (2021)

Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review
por: Fallet, Vincent, et al.
Publicado: (2021)

The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
por: Berzenji, Lawek, et al.
Publicado: (2021)

Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
por: Cortinovis, Diego, et al.
Publicado: (2021)

Current and future research efforts in oligometastatic non-small cell lung cancer—a systematic review
por: Brandão, Mariana, et al.
Publicado: (2021)

Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review
por: Mentink, Jill F., et al.
Publicado: (2021)

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis
por: Gobbini, Elisa, et al.
Publicado: (2021)

Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
por: Bertolaccini, Luca, et al.
Publicado: (2021)

Local for advanced, is this a paradox?
por: Bungaro, Maristella, et al.
Publicado: (2021)

Alternative methods for local ablation—interventional pulmonology: a narrative review
por: Olive, Gerard, et al.
Publicado: (2021)

The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions
por: Smith, Philippa, et al.
Publicado: (2023)

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center
por: Pierre, C., et al.
Publicado: (2021)

Diabetic Retinopathy: Battling the Global Epidemic
por: Das, Arup
Publicado: (2016)

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop
por: Nair, Prashant, et al.
Publicado: (2016)

Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases
por: Csaky, Karl, et al.
Publicado: (2018)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Report From the National Eye Institute Workshop on Neuro-Ophthalmic Disease Clinical Trial Endpoints: Optic Neuropathies
por: Levin, Leonard A., et al.
Publicado: (2021)

Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop
por: Levine, S. Robert, et al.
Publicado: (2023)

Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas
por: Matter, Matthias S., et al.
Publicado: (2020)

Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
por: Burke, Michael, et al.
Publicado: (2021)

Inflammatory Cytokine Profiles During Exercise in Obese, Diabetic, and Healthy Children
por: Galassetti, Pietro R., et al.
Publicado: (2011)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

The toxicity associated with combining immune check point inhibitors with tyrosine kinase inhibitors in patients with non-small cell lung cancer
por: Kalra, Anjali, et al.
Publicado: (2023)

Crizotinib治疗ALK阳性伴骨髓转移的肺腺癌1例及文献复习
Publicado: (2015)

EML4-ALK融合基因阳性肺腺癌合并淋巴瘤1例并文献复习
Publicado: (2015)

非小细胞肺癌患者EML4-ALK融合基因突变研究
Publicado: (2015)

ALK阳性非小细胞肺癌患者克唑替尼耐药的机制和治疗措施
Publicado: (2015)

初露端倪——演绎ALK阳性非小细胞肺癌的中国故事
Publicado: (2015)

增强免疫组化和原位杂交方法检测非小细胞肺癌的ALK重排的临床可行性
Publicado: (2015)

ALK阳性非小细胞肺癌的诊断
Publicado: (2015)

Classifying Oligometastatic Non-Small Cell Lung Cancer
por: Blumenthaler, Alisa N., et al.
Publicado: (2021)

The Implementation of Narrative Exposure Therapy (NET) for Transgender and Gender Diverse Adolescents and Young Adults
por: Julian, Jamie M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_at4fik1dt9dqb3ujpslkf09t90